More trials for SpectraScience colon probe:
This article was originally published in Clinica
US company SpectraScience has begun a new human trial of its Optical Biopsy system, an endoscopic device for early detection of colorectal cancer. The study will be conducted by a group of 40 Minnesota gastroenterologists.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.